See more : India Glycols Limited (INDIAGLYCO.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Sotera Health Company (SHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sotera Health Company, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Wiluna Mining Corporation Limited (WMC.AX) Income Statement Analysis – Financial Results
- China Enterprises Limited (CSHEF) Income Statement Analysis – Financial Results
- Da Hui Limited (5276.TWO) Income Statement Analysis – Financial Results
- ATAC Resources Ltd. (ATC.V) Income Statement Analysis – Financial Results
- Enterprise 4.0 Technology Acquisition Corp. (ENTFU) Income Statement Analysis – Financial Results
Sotera Health Company (SHC)
About Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 1.05B | 1.00B | 931.48M | 818.16M | 778.33M | 746.15M |
Cost of Revenue | 472.13M | 446.68M | 412.81M | 374.59M | 382.90M | 388.90M |
Gross Profit | 577.16M | 557.00M | 518.67M | 443.57M | 395.43M | 357.25M |
Gross Profit Ratio | 55.00% | 55.50% | 55.68% | 54.22% | 50.81% | 47.88% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 133.36M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 236.67M | 245.71M | 198.16M | 178.53M | 147.48M | 133.36M |
Other Expenses | 63.80M | 62.94M | 63.78M | 59.03M | 58.56M | 3.87M |
Operating Expenses | 300.47M | 308.65M | 261.94M | 237.55M | 206.04M | 191.34M |
Cost & Expenses | 772.60M | 755.34M | 674.75M | 612.14M | 588.94M | 580.24M |
Interest Income | 0.00 | 80.14M | 74.19M | 215.26M | 157.73M | 0.00 |
Interest Expense | 142.88M | 80.14M | 74.19M | 215.26M | 157.73M | 143.33M |
Depreciation & Amortization | 160.34M | 147.75M | 153.15M | 145.51M | 148.77M | 148.15M |
EBITDA | 420.20M | -2.99M | 404.25M | 319.96M | 305.25M | 316.60M |
EBITDA Ratio | 40.05% | 31.66% | 36.04% | 33.55% | 44.11% | 42.43% |
Operating Income | 276.69M | 248.35M | 256.73M | 206.02M | 183.60M | 80.85M |
Operating Income Ratio | 26.37% | 24.74% | 27.56% | 25.18% | 23.59% | 10.84% |
Total Other Income/Expenses | -170.67M | -491.46M | -81.02M | -244.88M | -184.51M | -56.63M |
Income Before Tax | 106.03M | -243.11M | 175.72M | -38.86M | -916.00K | 24.22M |
Income Before Tax Ratio | 10.10% | -24.22% | 18.86% | -4.75% | -0.12% | 3.25% |
Income Tax Expense | 54.65M | -9.54M | 58.60M | -1.37M | 19.51M | 30.10M |
Net Income | 51.38M | -233.57M | 116.88M | -37.49M | -20.43M | -5.87M |
Net Income Ratio | 4.90% | -23.27% | 12.55% | -4.58% | -2.62% | -0.79% |
EPS | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
EPS Diluted | 0.18 | -0.83 | 0.41 | -0.13 | -0.07 | -0.02 |
Weighted Avg Shares Out | 281.01M | 280.10M | 279.23M | 283.25M | 284.42M | 246.15M |
Weighted Avg Shares Out (Dil) | 283.22M | 280.10M | 279.38M | 283.25M | 284.42M | 246.15M |
Investors Of Sotera Health Company With Losses Surpassing $100,000 Are Encouraged To Initiate Contact By The Schall Law Firm
Sotera Health Company Investors With Losses Exceeding $100,000 Are Urged To Start Communication By The Schall Law Firm
The Schall Law Firm Appeals To Sotera Health Company Investors With Losses Above $100,000 To Commence Contact
Investors Of Sotera Health Company With Losses Over $100,000 Are Prompted By The Schall Law Firm To Start Communication
The Schall Law Firm Encourages Sotera Health Company Investors With Losses Surpassing $100,000 To Begin Interaction
The Schall Law Firm Urges Investors Of Sotera Health Company With Losses Exceeding $100,000 To Initiate Communication
The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Begin Contact
The Schall Law Firm Urges Investors In Sotera Health Company With Losses Exceeding $100,000 To Initiate Contact
The Schall Law Firm Encourages Investors In Sotera Health Company With Losses Surpassing $100,000 To Establish Communication
The Schall Law Firm Urges Investors In Sotera Health Company With Losses Exceeding $100,000 To Initiate Contact
Source: https://incomestatements.info
Category: Stock Reports